Complex Regional Pain Syndrome (CRPS) and the Gut-bacteria
Comparison of Gut Microbial Composition and Function in CRPS Patients vs. Healthy Individuals
1 other identifier
observational
250
1 country
1
Brief Summary
The purpose of this study is to investigate, for the first time, whether gut bacteria composition and function of patients with CRPS differ from those of healthy adults. Samples of stool, urine and blood will be collected from patients with CRPS and from healthy adults. The type and function of bacteria of CRPS patients will be analyzed and compared to those of healthy adults to test if potential differences could explain the mechanism/s involved with the development of CRPS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2022
CompletedStudy Start
First participant enrolled
April 14, 2022
CompletedFirst Posted
Study publicly available on registry
July 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedOctober 18, 2022
October 1, 2022
6 months
April 12, 2022
October 14, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Gut microbiome composition
Assessment of genomic composition of the gut bacteria by differential abundance analysis will be performed using 16S rRNA (Genome-Quebec)
1 day
Presence of stool microbiota-related metabolites affecting host physiology
Concentration of bile acids and short-chain-fatty-acids through Metabolomics analysis (Metabolon, USA).
1 day
Secondary Outcomes (4)
Short-form health-questionnaire (SF12) score
1 day
Brief Pain Inventory (BPI) score
1 day
Patient Health Questionnaire (PHQ-9) score
1 day
Pittsburg Sleep Quality Index (PSQI) scores
1 day
Study Arms (2)
CRPS (Complex Regional Pain Syndrome)
Participants with CRPS (Complex Regional Pain Syndrome))
Healthy
Healthy individuals
Interventions
fecal microbiome and metabolomics, as well as metabolites in plasma
physical examination performed by a physician to confirm CRPS diagnosis and assess patient's eligibility to participate in the study. The exam will include skin temperature measured using a laser/infrared skin thermometry.
Questionnaires measuring pain level, sleep, mood and diet parameters.
Eligibility Criteria
Adult women and men with CRPS and healthy volunteers.
You may qualify if:
- Women and men over the age of 18, diagnosed with CRPS of the upper or lower limb according to the Clinical Budapest Criteria, with a duration of 6 months and over (for the 1st study group).
- Healthy women and men over the age of 18, who share a household with a CRPS patients participating in the study (for the 1st control group).
- Healthy women and men over the age of 18 (for the 2nd control group).
- Be able to read and write in either French, English or Hebrew.
You may not qualify if:
- Any major illness (eg. malignancy, active inflammatory disease, metabolic disease, etc.)
- Pregnancy
- Chronic pain conditions (other than CRPS in the patients group)
- Acute illness of any type in the preceding 1 month
- Use of systemic antibiotics in the preceding 1 month
- Change in any other regularly taken medications in the past 1 month
- Substantial dietary / gastrointestinal alterations in the past 1 month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alan Edwards Pain Management Unit - Montreal General Hospital
Montreal, Quebec, H3G 1A4, Canada
Related Publications (4)
Birklein F, Ajit SK, Goebel A, Perez RSGM, Sommer C. Complex regional pain syndrome - phenotypic characteristics and potential biomarkers. Nat Rev Neurol. 2018 May;14(5):272-284. doi: 10.1038/nrneurol.2018.20. Epub 2018 Mar 16.
PMID: 29545626BACKGROUNDBirklein F, O'Neill D, Schlereth T. Complex regional pain syndrome: An optimistic perspective. Neurology. 2015 Jan 6;84(1):89-96. doi: 10.1212/WNL.0000000000001095. Epub 2014 Dec 3.
PMID: 25471395BACKGROUNDHarden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007 May-Jun;8(4):326-31. doi: 10.1111/j.1526-4637.2006.00169.x.
PMID: 17610454BACKGROUNDMinerbi A, Gonzalez E, Brereton NJB, Anjarkouchian A, Dewar K, Fitzcharles MA, Chevalier S, Shir Y. Altered microbiome composition in individuals with fibromyalgia. Pain. 2019 Nov;160(11):2589-2602. doi: 10.1097/j.pain.0000000000001640.
PMID: 31219947BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yoram Shir, MD
McGill University Health Centre/Research Institute of the McGill University Health Centre
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, the Alan Edwards Pain Management Unit
Study Record Dates
First Submitted
April 12, 2022
First Posted
July 25, 2022
Study Start
April 14, 2022
Primary Completion
October 14, 2022
Study Completion
June 30, 2024
Last Updated
October 18, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share